Cetera Investment Advisers
WGS icon

Cetera Investment Advisers’s GeneDx Holdings WGS Stock Holding History

Cetera Investment Advisers’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Sell
3,070
-546
-15% -$31K ﹤0.01% 4457
2026
Q1 		$232K Buy
3,616
+516
+17% +$47.1K ﹤0.01% 4179
2025
Q4 		$403K Sell
3,100
-383
-11% -$52.6K ﹤0.01% 3630
2025
Q3 		$375K Buy
3,483
+788
+29% +$85.9K ﹤0.01% 3629
2025
Q2 		$249K Buy
+2,695
New +$212K ﹤0.01% 3556

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Cetera Investment Advisers's WGS Position: Q2 2026 in Review

Cetera Investment Advisers reduced its GeneDx Holdings (WGS) stake by 15% in Q2 2026, selling an estimated $31K and leaving 3,070 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #4457.

Cetera Investment Advisers first reported a position in WGS in Q2 2025 and has held it in 5 quarters since. The position peaked at $403K in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Cetera Investment Advisers held 3,070 shares of GeneDx Holdings worth $211K as of Q2 2026.
  • Cetera Investment Advisers sold 546 GeneDx Holdings shares in Q2 2026, an estimated $31K.
  • GeneDx Holdings made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4457 holding.
  • Cetera Investment Advisers first reported a position in GeneDx Holdings in Q2 2025 and has held it in 5 quarters since.
  • Cetera Investment Advisers's GeneDx Holdings position peaked at $403K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.